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Abstract
A response to Louter-van de Haar J, Wielinga PY, Scheurink AJ, Nieuwenhuizen AG: Comparison
of the effects of three different (-)-hydroxycitric acid preparations on food intake in rats. Nutr
Metabol 2005, 2:23
Text
Louter-van de Haar J, et al. compared the effects of supple-
mentation of three commercially available (-)-hydroxy-
citric acid (HCA) preparations [Regulator, Citrin K and
Super CitriMax] on food intake and body weight. Two
doses (150 mg HCA/kg and 300 mg HCA/kg) were used
for each preparation over a period of four days. There are
significant flaws in this study, which we have outlined
below.
Two series of experiments were conducted. The first series
of experiments determined the effect of a single dose of
each preparation on food and water intake for the follow-
ing 46 hrs in a four-day placebo-controlled cross-over
experiment. In the second series of experiments, HCA
preparations were given twice a day for four days to study
the effects of repeated doses of the component on food
and water intake.
The authors concluded that Regulator and Citrin K were
shown to be potent inhibitors of food intake in rats,
whereas Super CitriMax showed only small and more
inconsistent effects.
There are several major weaknesses in this study, not the
least of which were the small number of animals used in
the study (n = 6 per group) and the short duration of the
experiment. It is also unclear what the sequencing was of
the supplements. It said that the animals were adminis-
tered either placebo or a treatment then were crossed-
over, but does not disclose which treatment groups were
administered before or after the placebo. For example, if
the Super CitriMax was administered before the placebo,
its appetite suppression effects may have been carried over
to the placebo portion of the experiment, minimizing any
differences; while much greater differences may have been
observed if the other treatments followed placebo admin-
istration. A 46-hour washout period was used, however,
there is no data to support this as being a sufficient
amount of time to clear the system of the effects of HCA
and, in fact, Super CitriMax's ability to boost serotonin
levels and reduce appetite may have carried over for sev-
eral days, resulting in reduced food intake in the placebo
group.
Furthermore, at the higher dosage levels where Regulator
and Citrin K were reported superior to Super CitriMax, the
food intake at the end of 24 hours of animals taking Super
CitriMax was actually less than that of animals taking
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either Regulator or Citrin K (20.0 versus 20.9 and 23.0,
respectively); however, for some reason the animals tak-
ing the placebo in the Super CitriMax group consumed
significantly less food than the animals consuming either
Regulator or Citrin K (19.6 versus 24.8 and 25.6, respec-
tively), thus the difference between the Super CitriMax
treatment and placebo groups was not as great. Was Super
CitriMax the only group to be given the treatment first fol-
lowed by the placebo?
Also, while the authors call four days a "long-term study,"
this is simply an inadequate period of time to demon-
strate consistent appetite suppression and weight loss
using HCA. HCA is a supplement, not a drug. Previous
studies using Super CitriMax, both in animals and
humans have demonstrated significant appetite suppres-
sion and weight loss over a greater span of time (six to
eight weeks) [1-3].
The authors state that the high calcium and low potassium
content of CitriMax (a calcium salt of HCA; 70% soluble
in water) may affect its solubility and bioavailability.
However, the authors are confusing CitriMax with Super
CitriMax, the latter being a novel calcium/potassium salt
of HCA that is highly water soluble (100%) and, in con-
trast to Regulator and Citrin-K, has been proven bioavail-
able in humans [4]. In addition, calcium offers the added
benefit of increasing lipid metabolism, resulting in lipol-
ysis and preserving thermogenesis during caloric restric-
tion, accelerating weight loss [5,6].
The authors further suggest that Super CitriMax may con-
sist of HCA lactone, a less effective form of HCA. How-
ever, HCA lactone analysis of Super CitriMax will show
that its lactone content is less than 1%.
It should also be noted that several independent studies
from multiple universities have shown that Super Cit-
riMax modulates important neurotransmitters (serot-
onin) and neuropeptides (neuropeptide Y) involved in
appetite control [6-8], something that Regulator and Cit-
rin K have not shown. Clinical studies on Super CitriMax
have demonstrated significant gradual reduction of appe-
tite as measured by remaining food over a period of eight
weeks [1,2], while no such human studies have been pub-
lished on Citrin K and Regulator. In any event, the present
study is an inadequate model for comparing HCA efficacy,
and the speculation the authors offer on Super CitriMax is
poorly informed.
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